Source: Eur Respir J, 49 (6) 1700848; 10.1183/13993003.00848-2017
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Lisette I.Z. Kunz, Nick H. ten Hacken, Thérèse S. Lapperre, Wim Timens, Huib A.M. Kerstjens, Annemarie van Schadewijk, Judith M. Vonk, Jacob K. Sont, Jiska B. Snoeck-Stroband, Dirkje S. Postma, Peter J. Sterk, Pieter S. Hiemstra. Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids. Eur Respir J, 49 (6) 1700848; 10.1183/13993003.00848-2017

Member's Comments

No comment yet.

Related content which might interest you: Airway inflammation and inhaled corticosteroids in COPD Source: Eur Respir J, 49 (6) 1700289; 10.1183/13993003.00289-2017 Year: 2017 Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids Source: International Congress 2016 – New findings in mucosal immunology Year: 2016 Dose response for inhaled fluticasone on airway and systemic inflammation in COPD Source: Annual Congress 2009 - Drug effects in COPD Year: 2009 Dose–response for inhaled fluticasone on airway and systemic inflammation in COPD Source: Eur Respir J 2011; 37: 206-209 Year: 2011 Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment Source: Eur Respir J 2006; 27: 964-971 Year: 2006 Effect of add-on montelukast to inhaled corticosteroids on excessive airway narrowing in adult asthmatics Source: Annual Congress 2009 - Aspects of clinical asthma Year: 2009 Inhaled corticosteroids decrease exercise-induced inflammation in patients with COPD Source: Annual Congress 2007 - Mechanisms of exercise intolerance in cardiorespiratory disease Year: 2007 Efficacy of systemic corticosteroids in refractory asthmatics showing no bronchial reversibility with high-dose inhaled corticosteroids or β2 agonist inhalation Source: Annual Congress 2010 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2010 Bronchodilator reversibility and short-term inhaled corticosteroid response in Japanese patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 341s Year: 2004 Effects of inhaled corticosteroids on asthmatic inflammation: The FeNOtype trial Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012 Inhaled corticosteroids in the treatment of acute asthma Source: Eur Respir J 2002; 20: Suppl. 38, 305s Year: 2002 Inhaled corticosteroids and growth of airway function in asthmatic children Source: Eur Respir J 2004; 23: 861-868 Year: 2004 ERS guideline on withdrawal of inhaled corticosteroids in COPD Source: ERS webinar 2021: ERS guideline on withdrawal of inhaled corticosteroids in COPD Year: 2021 Refractory asthmatics showing no bronchial reversibility with high-dose inhaled corticosteroids or β2 agonist inhalation: is this phenomenon airway remodeling? Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities Year: 2007 Inhaled steroids in exacerbations of COPD Source: Eur Respir J 2007; 30: 398 Year: 2007 Inhaled corticosteroids and hospitalisation due to exacerbation of COPD Source: Eur Respir J 2003; 22: 286-289 Year: 2003 Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness Source: Eur Respir J 2006; 27: 1144-1151 Year: 2006 Outcome of COPD exacerbations treated with and without oral steroids in relation to airway and systemic inflammation Source: Eur Respir J 2005; 26: Suppl. 49, 283s Year: 2005 The impact of stepwise withdrawal of inhaled corticosteroids on exacerbations in COPD patients receiving dual bronchodilation: WISDOM study Source: International Congress 2014 – Bronchodilators for asthma and COPD Year: 2014 Effects of inhaled corticosteroids on cough in asthma patients Source: Eur Respir J 2004; 24: Suppl. 48, 347s Year: 2004